1. Home
  2. TXMD vs GSIW Comparison

TXMD vs GSIW Comparison

Compare TXMD & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.23

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

GSIW

Garden Stage Limited

HOLD

Current Price

$0.06

Market Cap

28.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXMD
GSIW
Founded
2008
2016
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.9M
28.6M
IPO Year
2012
2022

Fundamental Metrics

Financial Performance
Metric
TXMD
GSIW
Price
$2.23
$0.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.0K
363.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
80.61
N/A
EPS
N/A
N/A
Revenue
$1,761,000.00
N/A
Revenue This Year
$427.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$90.64
N/A
Revenue Growth
35.25
N/A
52 Week Low
$0.72
$0.09
52 Week High
$2.95
$1.79

Technical Indicators

Market Signals
Indicator
TXMD
GSIW
Relative Strength Index (RSI) 49.23 13.47
Support Level $1.05 N/A
Resistance Level $2.54 $0.16
Average True Range (ATR) 0.13 0.01
MACD -0.02 -0.01
Stochastic Oscillator 40.91 3.75

Price Performance

Historical Comparison
TXMD
GSIW

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: